Rad Biomed Incubator Heraklion Final

RAD Biomed Incubator The Israeli incubator program started in 1991 to provide a sheltered environment for scientists and entrepreneurs from the former USSR RBM was established in 1992 as general incubator, refocused in 1998 to biotech Located in Tel-Aviv Owned by the RAD group of companies Six active graduate companies InnoScent Ltd MaimoniDex RA

9 Incubator companies The RAD Biomed Portfolio A RIO M EDICA T ouch M ed TissueDetect Drug-delivery pump Gene therapy Peripheral atherectomy Improved enzymes Molecular diagnostics Cord-blood harvesting Endoscopy Epidural-space detection Occu Pharma Opthalmic drug-delivery

Our Philosophy ,[object Object],[object Object],[object Object],To attain our goal we establish for each project a business model & strong IP position, and demonstrate that it can attain profitability in a targeted market segment

The Deal Flow ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Rad BioMed Functions as a mini Pre-Seed VC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],RAD BioMed’s Investment Committee Proactive search for projects Approval Product Positioning Incoming deal- flow Screening the deal-Flow

[object Object],[object Object],Nurturing T he Young Project While keeping our focus on the startup’s long term goals, we build the company’s work-plan & activities step-by-step to position it for the next round of financing ,[object Object],[object Object],[object Object],[object Object],[object Object]

Nurturing The People ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Funding ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],RBM maintains an active role in the fundraising process

Task Oriented Management Team Idan Tamir, Ph.D. President & CEO Binah Baum, Ph.D. MBA Director, Business Dev Shoshi Keynan, Ph.D. Project Manager Drug development specialists RAD group of companies Medical device consultants project IP experts Clinical & regulatory experts

Handling The Maturing Company Building Value To The Next Level √ Demonstrating proof of concept – critical milestone √ Creating a strong IP position with freedom to operate √ Initiating regulatory procedures – what does the FDA look for? Initiating discussion with regulatory consultants √ Preparing succinct business plan for next investment round √ Creating a professional advisory board & appointing a medical director √ Initiating alliances with companies e.g. FP7 consortia √ Helping to secure follow-up financing / alliances with strategic partners

Weaknesses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Strengths

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],What do we need to do in order “to do better” ? Janez Potocˇnick, European Commissioner for science and research

Rad Biomed Incubator Heraklion Final

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (20)

Ähnlich wie Rad Biomed Incubator Heraklion Final

Ähnlich wie Rad Biomed Incubator Heraklion Final (20)

Mehr von ignatiadis

Mehr von ignatiadis (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Rad Biomed Incubator Heraklion Final